BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32439379)

  • 21. Association between haptoglobin 2-2 genotype and coronary artery disease and its severity in a tunisian population.
    Moussa A; Rejeb J; Omezzine A; Rebhi L; Boumaiza I; Kacem S; Ben Rejeb N; Boughzala E; Ben Abdelaziz A; Bouslama A
    Biochem Genet; 2014 Jun; 52(5-6):269-82. PubMed ID: 24535155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke.
    Pelisek J; Eckstein HH; Zernecke A
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):431-42. PubMed ID: 22945688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
    Vormittag R; Vukovich T; Mannhalter C; Minar E; Schönauer V; Bialonczyk C; Hirschl M; Pabinger I
    Haematologica; 2005 Nov; 90(11):1557-61. PubMed ID: 16266904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque.
    Moreno PR; Purushothaman KR; Purushothaman M; Muntner P; Levy NS; Fuster V; Fallon JT; Lento PA; Winterstern A; Levy AP
    J Am Coll Cardiol; 2008 Sep; 52(13):1049-51. PubMed ID: 18848136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin.
    Cahill LE; Levy AP; Chiuve SE; Jensen MK; Wang H; Shara NM; Blum S; Howard BV; Pai JK; Mukamal KJ; Rexrode KM; Rimm EB
    J Am Coll Cardiol; 2013 Feb; 61(7):728-37. PubMed ID: 23312704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between the Apolipoprotein E Gene Polymorphism and Atherosclerotic Middle Cerebral Artery Stenosis.
    Zhang Z; Chen XY; Baum L; Ng HK; Mok V; Wong KS
    Neurologist; 2018 Mar; 23(2):47-50. PubMed ID: 29494434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Proteogenomic Analysis of Haptoglobin in Malaria.
    Awasthi G; Tyagi S; Kumar V; Patel SK; Rojh D; Sakrappanavar V; Kochar SK; Talukdar A; Samanta B; Das A; Srivastava S; Patankar S
    Proteomics Clin Appl; 2018 Jul; 12(4):e1700077. PubMed ID: 28960920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotype of haptoglobin and presence of subclinical vascular disease: Population study.
    Mostaza JM; de Dios O; Lahoz C; Arribas M; Pérez Arroyo A; Salinero-Fort MA; Laguna F; Estirado E; García-Iglesias F; González Alegre T; Sabín C; López S; Sánchez V; Cornejo V; Garcés C;
    Clin Investig Arterioscler; 2020; 32(1):1-7. PubMed ID: 31221534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia.
    Sertório JT; Lacchini R; Amaral LM; Palei AC; Cavalli RC; Sandrim VC; Duarte G; Tanus-Santos JE
    J Hum Hypertens; 2013 Jun; 27(6):349-54. PubMed ID: 23223086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.
    Armaly Z; Abd El Qader A; Jabbour A; Hassan K; Ramadan R; Bowirrat A; Bisharat B
    BMC Nephrol; 2015 Aug; 16():135. PubMed ID: 26268514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA polymorphisms in the controlling region of the human haptoglobin genes: a molecular explanation for the haptoglobin 2-1 modified phenotype.
    Maeda N
    Am J Hum Genet; 1991 Jul; 49(1):158-66. PubMed ID: 2063867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aneurysm formation in proinflammatory, transgenic haptoglobin 2-2 mice.
    Ruzevick J; Jackson C; Pradilla G; Garzon-Muvdi T; Tamargo RJ
    Neurosurgery; 2013 Jan; 72(1):70-6; discussion 76. PubMed ID: 23096414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.
    Asleh R; Miller-Lotan R; Aviram M; Hayek T; Yulish M; Levy JE; Miller B; Blum S; Milman U; Shapira C; Levy AP
    Circ Res; 2006 Dec; 99(12):1419-25. PubMed ID: 17082477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients.
    Yi X; Lin J; Luo H; Wang C; Liu Y
    PLoS One; 2017; 12(7):e0180704. PubMed ID: 28704403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Polymorphisms
    Yadav BK; Yadav R; Chang H; Choi K; Kim JT; Park MS; Kang HG; Choo I; Ahn SH; Oh DS; Ha YS; Kim I; Seo MW; Shin BS
    Ann Clin Lab Sci; 2017 Mar; 47(2):144-155. PubMed ID: 28442515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants in COX-2, PTGIS, and TBXAS1 Are Associated with Carotid Artery or Intracranial Arterial Stenosis and Neurologic Deterioration in Ischemic Stroke Patients.
    Yi X; Ming B; Wang C; Chen H; Ma C
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1128-1135. PubMed ID: 28108096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
    Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S
    Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency.
    Cahill LE; El-Sohemy A
    Am J Clin Nutr; 2010 Dec; 92(6):1494-500. PubMed ID: 20926521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haptoglobin polymorphism as a risk factor for chronic kidney disease: a case-control study.
    Chen YC; Lee CC; Huang CY; Huang HB; Yu CC; Ho YC; Su YC
    Am J Nephrol; 2011; 33(6):510-4. PubMed ID: 21546768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP Genetic Variants, CYP Metabolite Levels, and Symptomatic Carotid Stenosis in Ischemic Stroke Patients.
    Yi X; Liao D; Wu L; Chen H; Li J; Wang C
    J Atheroscler Thromb; 2016 May; 23(5):621-31. PubMed ID: 26686738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.